Literature DB >> 448424

Direct surgical treatment of bilateral intracavernous internal carotid artery aneurysms. Case report.

I Johnston.   

Abstract

Bilateral intracavernous internal carotid artery aneurysms are described in a 3-year-old child. The etiology was uncertain, although the aneurysms may have been mycotic. As there was clinical and radiological evidence of progressive enlargement of both aneurysms, the more conventional forms of treatment were not applicable. A direct surgical approach was made to both aneurysms with exploration of the intracavernous portion of the internal carotid artery under deep hypothermia and cardiac arrest.

Entities:  

Mesh:

Year:  1979        PMID: 448424     DOI: 10.3171/jns.1979.51.1.0098

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Endovascular treatment of infective aneurysms of the bilateral cavernous sinus: case report and review of the literature.

Authors:  Bo-Ra Seo; Tae-Sun Kim; Sung-Pil Joo; Sook-In Jung
Journal:  Klin Neuroradiol       Date:  2009-05-28

2.  Bilateral giant intracavernous carotid aneurysms in a 16-year-old boy.

Authors:  R K Winter; M D Hourihan; L G McKnight; N Powell
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

3.  Cavernous sinus surgery. Approach through the lateral wall.

Authors:  A Perneczky; E Knosp; C Matula
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 4.  Giant cerebral aneurysms.

Authors:  H W Pia; J Zierski
Journal:  Neurosurg Rev       Date:  1982       Impact factor: 3.042

5.  Bilateral aneurysms of the juxtasellar segment of the internal carotid artery.

Authors:  M A Haberbeck-Modesto; G Edner; T Greitz
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

Review 6.  Traumatic intracranial aneurysms in childhood and adolescence. Case reports and review of the literature.

Authors:  E C Ventureyra; M J Higgins
Journal:  Childs Nerv Syst       Date:  1994-08       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.